The stock has been rated “underperform.” Analysts from the Jefferies Group have said to “hold” on purchasing the company’s stock, while JPMorgan Chase gave it a “neutral” rating.
Victrex works with manufacturing of high performance polymers through its two business units, Invibio Biomaterial Solutions and Victrex Polymer Solutions.
More Articles on Devices:
MAKO Surgical Settles Lawsuit, Acquires Stanmore Robotic Assets
Stryker Releases Spine Screw, Surgical Devices
Sonoma Orthopedic Products Develops Minimally Invasive Technique For Fractures
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
